tm
Seeing Is Believing
tm
Seeing Is Believing
DNLI is currently covered by 11 analysts with an average price target of $33.76. This is a potential upside of $14.95 (46.08%) from yesterday's end of day stock price of $23.11.
Denali Therapeutics's activity chart (see below) currently has 173 price targets and 157 ratings on display. The stock rating distribution of DNLI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 30.16% with an average time for these price targets to be met of 109.23 days.
Highest price target for DNLI is $42, Lowest price target is $23, average price target is $33.76.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 23-Jul-2026. First documented stock forecast 02-Jan-2018.
Currently out of the existing stock ratings of DNLI, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jan-2018
$36
$12.89 (55.78%)
$35
4 days ago
(23-Jul-2026)
3/16 (18.75%)
$12.58 (53.71%)
389
Buy Since 13-Dec-2023
$35
$11.89 (51.45%)
$31
11 days ago
(16-Jul-2026)
1/5 (20%)
$12.27 (53.98%)
208
Buy Since 02-Jan-2018
$29
$5.89 (25.49%)
$26
14 days ago
(13-Jul-2026)
6/9 (66.67%)
$2.52 (9.52%)
199
Buy Since 07-Aug-2025
$39
$13.43 (52.52%)
$36
2 months 16 days ago
(11-May-2026)
1/7 (14.29%)
$19.33 (98.27%)
40
Buy Since 28-Feb-2020
$23
$-2.57 (-10.05%)
$31
2 months 19 days ago
(08-May-2026)
13/18 (72.22%)
$3.38 (17.23%)
108
What is DNLI (Denali Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DNLI (Denali Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DNLI (Denali Therapeutics)?
Which analyst is the currently most bullish on DNLI (Denali Therapeutics)?
Which analyst is the currently most reserved on DNLI (Denali Therapeutics)?
